- Home
- HLVX vs LEE Comparison
HLVX vs LEE Comparison
Compare HLVX & LEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLVX
- LEE
- Stock Information
- Founded
- HLVX 2020
- LEE 1890
- Country
- HLVX United States
- LEE United States
- Employees
- HLVX N/A
- LEE N/A
- Industry
- HLVX Biotechnology: Pharmaceutical Preparations
- LEE Newspapers/Magazines
- Sector
- HLVX Health Care
- LEE Consumer Discretionary
- Exchange
- HLVX Nasdaq
- LEE Nasdaq
- Market Cap
- HLVX 83.7M
- LEE N/A
- IPO Year
- HLVX 2022
- LEE N/A
- Fundamental
- Price
- HLVX $1.39
- LEE $10.32
- Analyst Decision
- HLVX Hold
- LEE
- Analyst Count
- HLVX 5
- LEE 0
- Target Price
- HLVX $2.33
- LEE N/A
- AVG Volume (30 Days)
- HLVX 126.8K
- LEE 18.7K
- Earning Date
- HLVX 03-28-2025
- LEE 05-01-2025
- Dividend Yield
- HLVX N/A
- LEE N/A
- EPS Growth
- HLVX N/A
- LEE N/A
- EPS
- HLVX N/A
- LEE N/A
- Revenue
- HLVX N/A
- LEE $600,264,000.00
- Revenue This Year
- HLVX N/A
- LEE N/A
- Revenue Next Year
- HLVX N/A
- LEE N/A
- P/E Ratio
- HLVX N/A
- LEE N/A
- Revenue Growth
- HLVX N/A
- LEE N/A
- 52 Week Low
- HLVX $1.41
- LEE $7.57
- 52 Week High
- HLVX $16.66
- LEE $19.63
- Technical
- Relative Strength Index (RSI)
- HLVX 20.06
- LEE 57.62
- Support Level
- HLVX $1.41
- LEE $10.00
- Resistance Level
- HLVX $1.71
- LEE $10.74
- Average True Range (ATR)
- HLVX 0.07
- LEE 0.64
- MACD
- HLVX -0.03
- LEE 0.29
- Stochastic Oscillator
- HLVX 7.50
- LEE 76.16
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.